Table of Content

1. Executive Summary
   1.1. Global Autologous Cell Therapy Market Snapshot, 2024 and 2031
   1.2. Market Opportunity Assessment, 2024 – 2031, US$ Mn
   1.3. Key Market Trends
   1.4. Future Market Projections
   1.5. Premium Market Insights
   1.6. Industry Developments and Key Market Events
   1.7. PMR Analysis and Recommendations

2. Market Overview
   2.1. Market Scope and Definition
   2.2. Market Dynamics
       2.2.1. Drivers
       2.2.2. Restraints
       2.2.3. Opportunity
       2.2.4. Challenges
       2.2.5. Key Trends
   2.3. Macro-Economic Factors
       2.3.1. Global Sectorial Outlook
       2.3.2. Global GDP Growth Outlook
       2.3.3. Global Healthcare Spending Outlook
   2.4. COVID-19 Impact Analysis
   2.5. Forecast Factors – Relevance and Impact

3. Value Added Insights
   3.1. Therapy Adoption Analysis
   3.2. Technology Assessment
   3.3. Regulatory Landscape
   3.4. Value Chain Analysis
       3.4.1. List of Distribution Channel/Marketplaces
           3.4.1.1. Retail
           3.4.1.2. Audiology
           3.4.1.3. E-Commerce
       3.4.2. List of End User (Industry)
   3.5. Key Deals and Mergers
   3.6. PESTLE Analysis
   3.7. Porter’s Five Force Analysis

4. Price Trend Analysis, 2018 – 2031
   4.1. Key Highlights
   4.2. Key Factors Impacting Therapy Prices
   4.3. Pricing Analysis, By Therapy
   4.4. Regional Prices and Therapy Preferences

5. Global Autologous Cell Therapy Market Outlook: Historical (2018 – 2023) and Forecast (2024 – 2031)
   5.1. Key Highlights
       5.1.1. Market Volume (Units) Projections
       5.1.2. Market Size (US$ Mn) and Y-o-Y Growth
       5.1.3. Absolute $ Opportunity
   5.2. Market Size (US$ Mn) Analysis and Forecast
       5.2.1. Historical Market Size (US$ Mn) Analysis, 2018-2022
       5.2.2. Current Market Size (US$ Mn) Analysis and Forecast, 2023–2031
   5.3. Global Autologous Cell Therapy Market Outlook: Therapy
       5.3.1. Introduction / Key Findings
       5.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Therapy, 2018 – 2022
       5.3.3. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Therapy, 2023 – 2031
           5.3.3.1. Autologous Cellular Immunotherapies
           5.3.3.2. Autologous Stem Cell Therapy
   5.4. Market Attractiveness Analysis: Therapy
   5.5. Global Autologous Cell Therapy Market Outlook: Application
       5.5.1. Introduction / Key Findings
       5.5.2. Historical Market Size (US$ Mn) Analysis, By Application, 2018 – 2022
       5.5.3. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2023 – 2031
           5.5.3.1. Cancer
           5.5.3.2. Neurodegenerative disorders
           5.5.3.3. Cardiovascular disorders
           5.5.3.4. Autoimmune disorders
           5.5.3.5. Orthopedics
           5.5.3.6. Wound healing
           5.5.3.7. Others
   5.6. Market Attractiveness Analysis: Application
   5.7. Global Autologous Cell Therapy Market Outlook: Source
       5.7.1. Introduction / Key Findings
       5.7.2. Historical Market Size (US$ Mn) Analysis, By Source, 2018 – 2022
       5.7.3. Current Market Size (US$ Mn) Analysis and Forecast, By Source, 2023 – 2031
           5.7.3.1. Bone Marrow
           5.7.3.2. Epidermis
           5.7.3.3. Mesenchymal stem cells
           5.7.3.4. Haematopoietic stem cells
           5.7.3.5. Chondrocytes
           5.7.3.6. Others
   5.8. Market Attractiveness Analysis: Source Global Autologous Cell Therapy Market Outlook: End Use
       5.8.1. Introduction / Key Findings
       5.8.2. Historical Market Size (US$ Mn) Analysis, By End Use, 2018 – 2022
       5.8.3. Current Market Size (US$ Mn) Analysis and Forecast, By End Use, 2023 – 2031
           5.8.3.1. Hospitals & Clinics
           5.8.3.2. Ambulatory Centers
           5.8.3.3. Academics & Research
           5.8.3.4. Others
   5.9. Market Attractiveness Analysis: Source

6. Global Autologous Cell Therapy Market Outlook: Region
   6.1. Key Highlights
   6.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Region, 2018 – 2022
   6.3. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Region, 2023 – 2031
       6.3.1. North America
       6.3.2. Europe
       6.3.3. East Asia
       6.3.4. South Asia and Oceania
       6.3.5. Latin America
       6.3.6. Middle East & Africa
   6.4. Market Attractiveness Analysis: Region

7. North America Autologous Cell Therapy Market Outlook: Historical (2018 – 2023) and Forecast (2024 – 2031)
   7.1. Key Highlights
   7.2. Pricing Analysis
   7.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Market, 2018 – 2022
       7.3.1. By Country
       7.3.2. By Therapy
       7.3.3. By Application
       7.3.4. By Source
       7.3.5. By End Use
   7.4. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 – 2031
       7.4.1. U.S.
       7.4.2. Canada
   7.5. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Therapy, 2023 – 2031
       7.5.1. Autologous Cellular Immunotherapies
       7.5.2. Autologous Stem Cell Therapy
   7.6. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2023 – 2031
       7.6.1. Cancer
       7.6.2. Neurodegenerative disorders
       7.6.3. Cardiovascular disorders
       7.6.4. Autoimmune disorders
       7.6.5. Orthopedics
       7.6.6. Wound healing
       7.6.7. Others
   7.7. Current Market Size (US$ Mn) Analysis and Forecast, By Source, 2023 – 2031
       7.7.1. Bone Marrow
       7.7.2. Epidermis
       7.7.3. Mesenchymal stem cells
       7.7.4. Haematopoietic stem cells
       7.7.5. Chondrocytes
       7.7.6. Others
   7.8. Current Market Size (US$ Mn) Analysis and Forecast, By End Use, 2023 – 2031
       7.8.1. Hospitals & Clinics
       7.8.2. Ambulatory Centers
       7.8.3. Academics & Research
       7.8.4. Others
   7.9. Market Attractiveness Analysis

8. Europe Autologous Cell Therapy Market Outlook: Historical (2018 – 2023) and Forecast (2024 – 2031)
   8.1. Key Highlights
   8.2. Pricing Analysis
   8.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Market, 2018 – 2022
       8.3.1. By Country
       8.3.2. By Therapy
       8.3.3. By Application
       8.3.4. By Source
       8.3.5. By End Use
   8.4. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 – 2031
       8.4.1. Germany
       8.4.2. France
       8.4.3. U.K.
       8.4.4. Italy
       8.4.5. Spain
       8.4.6. Russia
       8.4.7. Türkiye
       8.4.8. Rest of Europe
   8.5. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Therapy, 2023 – 2031
       8.5.1. Autologous Cellular Immunotherapies
       8.5.2. Autologous Stem Cell Therapy
   8.6. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2023 – 2031
       8.6.1. Cancer
       8.6.2. Neurodegenerative disorders
       8.6.3. Cardiovascular disorders
       8.6.4. Autoimmune disorders
       8.6.5. Orthopedics
       8.6.6. Wound healing
       8.6.7. Others
   8.7. Current Market Size (US$ Mn) Analysis and Forecast, By Source, 2023 – 2031
       8.7.1. Bone Marrow
       8.7.2. Epidermis
       8.7.3. Mesenchymal stem cells
       8.7.4. Haematopoietic stem cells
       8.7.5. Chondrocytes
       8.7.6. Others
   8.8. Current Market Size (US$ Mn) Analysis and Forecast, By End Use, 2023 – 2031
       8.8.1. Hospitals & Clinics
       8.8.2. Ambulatory Centers
       8.8.3. Academics & Research
       8.8.4. Others
   8.9. Market Attractiveness Analysis

9. East Asia Autologous Cell Therapy Market Outlook: Historical (2018 – 2023) and Forecast (2024 – 2031)
   9.1. Key Highlights
   9.2. Pricing Analysis
   9.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Market, 2018 – 2022
       9.3.1. By Country
       9.3.2. By Therapy
       9.3.3. By Application
       9.3.4. By Source
       9.3.5. By End Use
   9.4. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 – 2031
       9.4.1. China
       9.4.2. Japan
       9.4.3. South Korea
   9.5. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Therapy, 2023 – 2031
       9.5.1. Autologous Cellular Immunotherapies
       9.5.2. Autologous Stem Cell Therapy
   9.6. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2023 – 2031
       9.6.1. Cancer
       9.6.2. Neurodegenerative disorders
       9.6.3. Cardiovascular disorders
       9.6.4. Autoimmune disorders
       9.6.5. Orthopedics
       9.6.6. Wound healing
       9.6.7. Others
   9.7. Current Market Size (US$ Mn) Analysis and Forecast, By Source, 2023 – 2031
       9.7.1. Bone Marrow
       9.7.2. Epidermis
       9.7.3. Mesenchymal stem cells
       9.7.4. Haematopoietic stem cells
       9.7.5. Chondrocytes
       9.7.6. Others
   9.8. Current Market Size (US$ Mn) Analysis and Forecast, By End Use, 2023 – 2031
       9.8.1. Hospitals & Clinics
       9.8.2. Ambulatory Centers
       9.8.3. Academics & Research
       9.8.4. Others
   9.9. Market Attractiveness Analysis

10. South Asia & Oceania Autologous Cell Therapy Market Outlook: Historical (2018 – 2023) and Forecast (2024 – 2031)
   10.1. Key Highlights
   10.2. Pricing Analysis
   10.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Market, 2018 – 2022
       10.3.1. By Country
       10.3.2. By Therapy
       10.3.3. By Application
       10.3.4. By Source
       10.3.5. By End Use
   10.4. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 – 2031
       10.4.1. India
       10.4.2. Southeast Asia
       10.4.3. ANZ
       10.4.4. Rest of South Asia & Oceania
   10.5. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Therapy, 2023 – 2031
       10.5.1. Autologous Cellular Immunotherapies
       10.5.2. Autologous Stem Cell Therapy
   10.6. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2023 – 2031
       10.6.1. Cancer
       10.6.2. Neurodegenerative disorders
       10.6.3. Cardiovascular disorders
       10.6.4. Autoimmune disorders
       10.6.5. Orthopedics
       10.6.6. Wound healing
       10.6.7. Others
   10.7. Current Market Size (US$ Mn) Analysis and Forecast, By Source, 2023 – 2031
       10.7.1. Bone Marrow
       10.7.2. Epidermis
       10.7.3. Mesenchymal stem cells
       10.7.4. Haematopoietic stem cells
       10.7.5. Chondrocytes
       10.7.6. Others
   10.8. Current Market Size (US$ Mn) Analysis and Forecast, By End Use, 2023 – 2031
       10.8.1. Hospitals & Clinics
       10.8.2. Ambulatory Centers
       10.8.3. Academics & Research
       10.8.4. Others
   10.9. Market Attractiveness Analysis

11. Latin America Autologous Cell Therapy Market Outlook: Historical (2018 – 2023) and Forecast (2024 – 2031)
   11.1. Key Highlights
   11.2. Pricing Analysis
   11.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Market, 2018 – 2022
       11.3.1. By Country
       11.3.2. By Therapy
       11.3.3. By Application
       11.3.4. By Source
       11.3.5. By End Use
   11.4. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 – 2031
       11.4.1. Brazil
       11.4.2. Mexico
       11.4.3. Rest of Latin America
   11.5. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Therapy, 2023 – 2031
       11.5.1. Autologous Cellular Immunotherapies
       11.5.2. Autologous Stem Cell Therapy
   11.6. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2023 – 2031
       11.6.1. Cancer
       11.6.2. Neurodegenerative disorders
       11.6.3. Cardiovascular disorders
       11.6.4. Autoimmune disorders
       11.6.5. Orthopedics
       11.6.6. Wound healing
       11.6.7. Others
   11.7. Current Market Size (US$ Mn) Analysis and Forecast, By Source, 2023 – 2031
       11.7.1. Bone Marrow
       11.7.2. Epidermis
       11.7.3. Mesenchymal stem cells
       11.7.4. Haematopoietic stem cells
       11.7.5. Chondrocytes
       11.7.6. Others
   11.8. Current Market Size (US$ Mn) Analysis and Forecast, By End Use, 2023 – 2031
       11.8.1. Hospitals & Clinics
       11.8.2. Ambulatory Centers
       11.8.3. Academics & Research
       11.8.4. Others
   11.9. Market Attractiveness Analysis

12. Middle East & Africa Autologous Cell Therapy Market Outlook: Historical (2018 – 2023) and Forecast (2024 – 2031)
   12.1. Key Highlights
   12.2. Pricing Analysis
   12.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Market, 2018 – 2022
       12.3.1. By Country
       12.3.2. By Therapy
       12.3.3. By Application
       12.3.4. By Source
       12.3.5. By End Use
   12.4. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 – 2031
       12.4.1. GCC Countries
       12.4.2. Egypt
       12.4.3. South Africa
       12.4.4. Northern Africa
       12.4.5. Rest of Middle East & Africa
   12.5. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Therapy, 2023 – 2031
       12.5.1. Autologous Cellular Immunotherapies
       12.5.2. Autologous Stem Cell Therapy
   12.6. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2023 – 2031
       12.6.1. Cancer
       12.6.2. Neurodegenerative disorders
       12.6.3. Cardiovascular disorders
       12.6.4. Autoimmune disorders
       12.6.5. Orthopedics
       12.6.6. Wound healing
       12.6.7. Others
   12.7. Current Market Size (US$ Mn) Analysis and Forecast, By Source, 2023 – 2031
       12.7.1. Bone Marrow
       12.7.2. Epidermis
       12.7.3. Mesenchymal stem cells
       12.7.4. Haematopoietic stem cells
       12.7.5. Chondrocytes
       12.7.6. Others
   12.8. Current Market Size (US$ Mn) Analysis and Forecast, By End Use, 2023 – 2031
       12.8.1. Hospitals & Clinics
       12.8.2. Ambulatory Centers
       12.8.3. Academics & Research
       12.8.4. Others
   12.9. Market Attractiveness Analysis

13. Competition Landscape
   13.1. Market Share Analysis, 2023
   13.2. Market Structure
       13.2.1. Competition Intensity Mapping By Market
       13.2.2. Competition Dashboard
   13.3. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)
       13.3.1. BrainStorm Cell Therapeutics
           13.3.1.1. Overview
           13.3.1.2. Segments and Therapys
           13.3.1.3. Key Financials
           13.3.1.4. Market Developments
           13.3.1.5. Market Strategy
       13.3.2. Holostem Terapie Avanzate S.R.L
       13.3.3. Pharmicell Co. Inc
       13.3.4. Opexa Therapeutics
       13.3.5. Lonza
       13.3.6. Bristol Myers Squibb
       13.3.7. Tego Science
       13.3.8. Corning Incorporated
       13.3.9. Bio Elpida
       13.3.10. Novartis
       13.3.11. Autolus therapeutics
       13.3.12. Vericel Corporation
       13.3.13. Catalent, Inc
       13.3.14. Sartorius AG

14. Appendix
   14.1. Research Methodology
   14.2. Research Assumptions
   14.3. Acronyms and Abbreviations